-
Je něco špatně v tomto záznamu ?
Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase
R. Nencka, I. Votruba, H. Hřebabecký, P. Jansa, E. Tloušt'ová, K. Horská, M. Masojídková, A. Holý
Jazyk angličtina Země Spojené státy americké
- MeSH
- financování organizované MeSH
- inhibitory angiogeneze chemická syntéza chemie MeSH
- kinetika MeSH
- lidé MeSH
- molekulární modely MeSH
- thymidinfosforylasa antagonisté a inhibitory MeSH
- uracil analogy a deriváty chemická syntéza chemie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
Thymidine phosphorylase plays an important role in angiogenesis, which is an attractive target for therapy of cancer and other diseases. In our continuous effort to develop novel inhibitors of thymidine phosphorylase, we have discovered that 6-halouracils substituted at position C5 by certain hydrophobic groups exhibit significant inhibitory activity against this enzyme. The most potent compounds bear a five- or six-membered cyclic substituent containing a pi-electron system at C5 and a chlorine atom attached at C6. 6-Chloro-5-cyclopent-1-en-1-yluracil 7a is the most efficient derivative in this study, with Ki = 0.20 +/- 0.03 microM (Ki/dThdKm = 0.0017) for thymidine phosphorylase expressed in V79 cells and Ki = 0.29 +/- 0.04 microM (Ki/dThdKm = 0.0024) for the enzyme purified from placenta.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026293
- 003
- CZ-PrNML
- 005
- 20120717233155.0
- 008
- 101018s2007 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Nencka, Radim $7 xx0128812
- 245 10
- $a Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase / $c R. Nencka, I. Votruba, H. Hřebabecký, P. Jansa, E. Tloušt'ová, K. Horská, M. Masojídková, A. Holý
- 314 __
- $a Gilead Sciences & IOCB Research Centre, Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Centre for New Antivirals and Antineoplastics, Flemingovo nam. 2, Prague 6, Czech Republic. nencka@uochb.cas.cz
- 520 9_
- $a Thymidine phosphorylase plays an important role in angiogenesis, which is an attractive target for therapy of cancer and other diseases. In our continuous effort to develop novel inhibitors of thymidine phosphorylase, we have discovered that 6-halouracils substituted at position C5 by certain hydrophobic groups exhibit significant inhibitory activity against this enzyme. The most potent compounds bear a five- or six-membered cyclic substituent containing a pi-electron system at C5 and a chlorine atom attached at C6. 6-Chloro-5-cyclopent-1-en-1-yluracil 7a is the most efficient derivative in this study, with Ki = 0.20 +/- 0.03 microM (Ki/dThdKm = 0.0017) for thymidine phosphorylase expressed in V79 cells and Ki = 0.29 +/- 0.04 microM (Ki/dThdKm = 0.0024) for the enzyme purified from placenta.
- 650 _2
- $a inhibitory angiogeneze $x chemická syntéza $x chemie $7 D020533
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a thymidinfosforylasa $x antagonisté a inhibitory $7 D013939
- 650 _2
- $a uracil $x analogy a deriváty $x chemická syntéza $x chemie $7 D014498
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Votruba, Ivan, $d 1942- $7 xx0030600
- 700 1_
- $a Hřebabecký, Hubert $7 xx0077428
- 700 1_
- $a Jansa, Petr. $7 _AN053809
- 700 1_
- $a Tloušťová, Eva $7 xx0118948
- 700 1_
- $a Horská, Květoslava $7 xx0076627
- 700 1_
- $a Masojídková, Milena $7 xx0128761
- 700 1_
- $a Holý, Antonín, $d 1936-2012 $7 jn20000401004
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $g Roč. 50, č. 24 (2007), s. 6016-6023 $x 0022-2623
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20101116101433 $b ABA008
- 991 __
- $a 20120717233139 $b ABA008
- 999 __
- $a ok $b bmc $g 801398 $s 666143
- BAS __
- $a 3
- BMC __
- $a 2007 $b 50 $c 24 $d 6016-6023 $i 0022-2623 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a 2010-B/jtme